Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.290, sa.2, ss.321-328, 2014 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 290 Sayı: 2
- Basım Tarihi: 2014
- Doi Numarası: 10.1007/s00404-014-3217-5
- Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.321-328
- Anahtar Kelimeler: Hirsutism, Hyperandrogenism, Insulin resistance, Oral contraceptive, Polycystic ovary syndrome, LONG-TERM TREATMENT, C-REACTIVE PROTEIN, INSULIN-RESISTANCE, ETHINYL ESTRADIOL, WOMEN, METABOLISM, HOMOCYSTEINE, MANAGEMENT, ANDROGEN, DYSLIPIDEMIA
- Ankara Üniversitesi Adresli: Evet
Özet
To compare the effects of combined oral contraceptives (OCs) containing cyproterone acetate and drospirenone in the treatment of polycystic ovary syndrome (PCOS).